American Tower(AMT)

Search documents
American Tower Stock Falls 16% in 3 Months: Time to Buy, Sell or Hold?
ZACKS· 2024-12-12 17:41
Shares of American Tower (AMT) have experienced a more than 16% decline in the past three months, closing at $199.59 on Wednesday on the NYSE. In the past three months, the stock has underperformed the Zacks REIT and Equity Trust - Other industry and the S&P 500 composite.This prominent independent owner, operator and developer of multitenant communications real estate has faced a few challenges this year, hindering its growth trajectory. Its sale of the troubled Indian tower operations to Data Infrastructu ...
American Tower Corporation (AMT) UBS Global Media & Communications Conference (Transcript)
2024-12-10 20:35
American Tower Corporation (NYSE:AMT) UBS Global Media & Communications Conference December 10, 2024 12:45 PM ET Company Participants Rod Smith - EVP and CFO Conference Call Participants Batya Levi - UBS Batya Levi Great. Thanks, everyone, joining our next session with American Tower. Excited to have Rod Smith, EVP and CFO with us. And I'm Batya Levi with the communications team at UBS. Rod, thank you so much for joining us. Rod Smith You're welcome. Thanks for having me. It's great to be here. Batya Levi G ...
2 Magnificent S&P 500 Dividend Stocks to Buy for a Lifetime of Passive Income
The Motley Fool· 2024-12-01 11:30
Finding stocks that have long-lasting megatrends working in their favor can be an excellent way to generate new investment ideas. This notion is especially true when the businesses are market share leaders in their niche.Two companies that meet these requirements are American Tower (AMT -0.14%) and Public Storage (PSA -0.94%). If people are using data or need room to store things, these two stocks will likely benefit. With total returns of 760% and 3,590% since 2000 compared to the S&P 500's mark of 540%, t ...
The U.S. Election's Impact On REITs
Seeking Alpha· 2024-11-30 13:15
The decisive electoral victory of Donald Trump and the Republican Party sent an immediate shock wave through the stock market, as investors quickly priced in the new reality awaiting us in 2025 and beyond.If you want full access to our Portfolio and all our current Top Picks, feel free to join us at High Yield Landlord for a 2-week free trial.We are the largest and best-rated real estate investor community on Seeking Alpha with 2,000+ members on board and a 4.9 /5 rating from 500+ reviews:You won't be charg ...
Should You Retain American Tower Stock in Your Portfolio Now?
ZACKS· 2024-11-25 19:00
American Tower (AMT) boasts an extensive, geographically diversified communication real estate portfolio. The company will likely benefit from increased investment by wireless carriers in 4G and 5G networks. Solid business fundamentals and a prudent capital-allocation strategy augur well for growth.However, high customer concentration and the ongoing consolidation in the wireless industry are likely to weigh on its top-line growth.What’s Aiding AMT?The advancement in mobile technology, such as 4G and 5G, an ...
3 REITs With High Dividend Growth Prospects In 2025
Seeking Alpha· 2024-11-21 13:15
Maybe “hate” is too strong a word, but we certainly would never invest our money into them or recommend othersWe love real estate investment trusts (“REITs”), but we hate REIT ETFs ( VNQ ) and mutual funds.If you want full access to our Portfolio and all our current Top Picks, feel free to join us at High Yield Landlord for a 2-week free trial.We are the largest and best-rated real estate investor community on Seeking Alpha with 2,000+ members on board and a 4.9 /5 rating from 500+ reviews:You won't be char ...
uniQure Announces Dosing of First Patient in GenTLE Phase I/IIa Clinical Trial of AMT-260 for the Treatment of Refractory Mesial Temporal Lobe Epilepsy
GlobeNewswire News Room· 2024-11-21 12:05
LEXINGTON, Mass. and AMSTERDAM, Nov. 21, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the first patient has been dosed in the GenTLE Phase I/IIa clinical trial of AMT-260 for the treatment of refractory mesial temporal lobe epilepsy (MTLE). “The dosing of the first patient in our Phase I/II trial in temporal lobe epilepsy represents an important milestone for uniQure and ou ...
American Tower: An Undervalued Dividend Stock Benefiting From Durable Competitive Advantages
Seeking Alpha· 2024-11-18 14:00
Founder of Dividend Mantra. Founder of Mr. Free At 33. Co-Founder of Dividends & Income. I started blogging about my journey to financial independence back in 2011. By living well below my means and intelligently investing my hard-earned capital, I went from below broke at age 27 to financially free at 33 years old. I regularly create content on dividend growth investing, living off of dividends, undervalued high-quality dividend growth stocks, high-yield situations, and other long-term investment opportuni ...
Unabated Demand Could Drive Towering Growth for This Top Dividend Stock in 2025 and Beyond
The Motley Fool· 2024-11-01 09:42
American Tower's growth headwinds should fade next year.American Tower (AMT 0.03%) has encountered a few speedbumps over the past year, which has slowed its growth. As a result, the infrastructure-focused real estate investment trust (REIT) hasn't been able to increase its dividend. That's a notable departure for a company that had delivered more than 20% annual dividend growth since 2013. The infrastructure REIT's headwinds are masking the unabated demand it's seeing for communications and data infrastruct ...
American Tower(AMT) - 2024 Q3 - Quarterly Report
2024-10-29 20:05
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One): ☒ Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the quarterly period ended September 30, 2024. ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. Commission File Number: 001-14195 | --- | --- | --- | |----------------------------------------------------------------------------|---------------------------------------------------- ...